| 000 | 01690 a2200565 4500 | ||
|---|---|---|---|
| 005 | 20250517032120.0 | ||
| 264 | 0 | _c20151117 | |
| 008 | 201511s 0 0 eng d | ||
| 022 | _a0026-4733 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSilvestri, S | |
| 245 | 0 | 0 |
_aRole of TachoSil® in distal pancreatectomy: a single center experience. _h[electronic resource] |
| 260 |
_bMinerva chirurgica _cJun 2015 |
||
| 300 |
_a175-80 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aBlood Loss, Surgical _xstatistics & numerical data |
| 650 | 0 | 4 | _aDrug Combinations |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFibrinogen _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIncidence |
| 650 | 0 | 4 |
_aItaly _xepidemiology |
| 650 | 0 | 4 |
_aLength of Stay _xstatistics & numerical data |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aOperative Time |
| 650 | 0 | 4 |
_aPancreatectomy _xadverse effects |
| 650 | 0 | 4 |
_aPancreatic Fistula _xprevention & control |
| 650 | 0 | 4 |
_aPancreatic Neoplasms _xpathology |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 |
_aThrombin _xadministration & dosage |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aFranchello, A | |
| 700 | 1 | _aGonella, F | |
| 700 | 1 | _aDeiro, G | |
| 700 | 1 | _aCampra, D | |
| 700 | 1 | _aCassine, D | |
| 700 | 1 | _aFiore, A | |
| 700 | 1 | _aOstuni, E | |
| 700 | 1 | _aGarino, M | |
| 700 | 1 | _aResegotti, A | |
| 700 | 1 | _aFarina, E C | |
| 700 | 1 | _aFronda, G R | |
| 773 | 0 |
_tMinerva chirurgica _gvol. 70 _gno. 3 _gp. 175-80 |
|
| 999 |
_c24886916 _d24886916 |
||